ARROWHEAD PHARMACEUTICALS, INC.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 8-K | 8-K | Mar 20, 2026 |
| 4 | FORM 4 | Mar 9, 2026 |
| 144 | — | Mar 5, 2026 |
| 10-Q | 10-Q | Feb 5, 2026 |
| 8-K | 8-K | Feb 5, 2026 |
| DEFA14A | DEFA14A | Jan 27, 2026 |
| DEF 14A | DEF 14A | Jan 27, 2026 |
| ARS | ARS | Jan 27, 2026 |
| SCHEDULE 13G/A | — | Jan 21, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Ferrari Mauro | — | Sale | 7,530 @ $70.00 | Dec 26, 2025 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 10,012 @ $68.33 | Dec 22, 2025 |
| Waddill William D. | — | Sale | 500 @ $68.53 | Dec 19, 2025 |
| Vakiener Victoria | — | Sale | 5,281 @ $67.97 | Dec 19, 2025 |
| OLUKOTUN ADEOYE Y | — | Sale | 827 @ $68.48 | Dec 19, 2025 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 46,287 @ $63.55 | Dec 17, 2025 |
| Ferrari Mauro | — | Award / Grant | 7,819 | Dec 16, 2025 |
| Lu Hongbo | — | Award / Grant | 7,819 | Dec 16, 2025 |
| PERRY MICHAEL S | — | Award / Grant | 7,819 | Dec 16, 2025 |
| Vakiener Victoria | — | Award / Grant | 7,819 | Dec 16, 2025 |